|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.50 CZK | -2.25% |
|
-5.65% | -36.18% |
| 15/06 | Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt | CI |
| 15/06 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Company Valuation: Pilulka Lékárny
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 4,212 | 1,639 | 665.8 | 291 | 460.1 |
| Change | - | -61.1% | -59.37% | -56.3% | 58.14% |
| Enterprise Value (EV) 1 | 4,141 | 1,618 | 732 | 329.2 | 499.8 |
| Change | - | -60.93% | -54.76% | -55.02% | 51.8% |
| P/E | - | -25.2x | -3.81x | -2.31x | -11.8x |
| PBR | - | 11.7x | 20.3x | -3.1x | -3.44x |
| PEG | - | - | -0x | 0.1x | 0.2x |
| Capitalization / Revenue | 1.77x | 0.67x | 0.31x | 0.22x | 0.53x |
| EV / Revenue | 1.74x | 0.66x | 0.34x | 0.25x | 0.57x |
| EV / EBITDA | 501x | -54.1x | -5.82x | -3.65x | -329x |
| EV / EBIT | -295x | -33.9x | -4.93x | -3x | -30.3x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | -25.76 | -64.63 | -46.46 | -14.36 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 2,380 | 2,447 | 2,132 | 1,304 | 876.4 |
| EBITDA 1 | 8.262 | -29.89 | -125.7 | -90.27 | -1.521 |
| EBIT 1 | -14.05 | -47.74 | -148.6 | -109.9 | -16.48 |
| Net income 1 | -25.5 | -64.94 | -174.9 | -125.7 | -38.87 |
| Net Debt 1 | -71.61 | -20.67 | 66.16 | 38.28 | 39.66 |
| Reference price 2 | 1,685.00 | 650.00 | 246.00 | 107.50 | 170.00 |
| Nbr of stocks (in thousands) | 2,500 | 2,521 | 2,707 | 2,707 | 2,707 |
| Announcement Date | 04/04/23 | 04/04/23 | 29/05/24 | 25/04/25 | 15/06/26 |
1CZK in Million2CZK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.38Cr | |
| 17.56x | 0.73x | 11.51x | -.--% | 1.52TCr | |
| 21.47x | 1.07x | 16.5x | -.--% | 715.47Cr | |
| 15.93x | 0.71x | 7.4x | 2.34% | 590.12Cr | |
| 12.72x | 0.81x | 5.82x | 3.37% | 359.58Cr | |
| 15.5x | 0.94x | 7.02x | 4.17% | 322.78Cr | |
| 14.23x | 1.22x | 7.35x | 5.73% | 318.19Cr | |
| 13.54x | 0.55x | 4.41x | 5.1% | 296.45Cr | |
| 39.96x | - | - | - | 259.36Cr | |
| Average | 18.86x | 0.86x | 8.57x | 2.96% | 487.03Cr | |
| Weighted average by Cap. | 18.24x | 0.83x | 10.11x | 1.76% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PINK Stock
- Valuation Pilulka Lékárny
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
